CRISPR dispute raises bigger patent issues that we're not talking about
Monday, April 4, 2016 - 08:31
in Mathematics & Economics
The worlds of science, technology and patent law eagerly await the U.S. government's decision on who deserves patents on what many have referred to as the biotechnology invention of the century: the CRISPR/Cas9 gene-editing technique.